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Amyotrophic lateral sclerosis (ALS) is a fatal adult-onset disease in which motor neurons in the brain and spinal
cord degenerate by largely unknown mechanisms. ALS is familial (FALS) in 10% of cases, and the inheritance is
usually dominant, with variable penetrance. Mutations in copper/zinc super oxide dismutase (SOD1) are found in
20% of familial and 3% of sporadic ALS cases. Five families with ALS and frontotemporal dementia (ALS-FTD)
are linked to 9q21, whereas one family with pure ALS is linked to 18q21. We identified two large European families
with ALS without SOD1 mutations or linkage to known FALS loci and conducted a genomewide linkage screen
using 400 microsatellite markers. In both families, two-point LOD scores 11 and a haplotype segregating with
disease were demonstrated only across regions of chromosome 16. Subsequent fine mapping in family 1 gave a
maximum two-point LOD score of 3.62 at D16S3137 and a three-point LOD score of 3.85 for markers D16S415
and D16S3137. Haplotype analysis revealed no recombination 1∼30 cM, (flanking markers at D16S3075 and
D16S3112). The maximum two-point LOD score for family 2 was 1.84 at D16S415, and the three-point LOD
score was 2.10 for markers D16S419 and D16S415. Definite recombination occurred in several individuals, which
narrowed the shared haplotype in affected individuals to a 10.1-cM region (flanking markers: D16S3396 and
D16S3112). The region shared by both families on chromosome 16q12 corresponds to ∼4.5 Mb on the Marshfield
map. Bioinformatic analysis of the region has identified 18 known genes and 70 predicted genes in this region,
and sequencing of candidate genes has now begun.
Amyotrophic lateral sclerosis (ALS) is a greatly disabling
and ultimately fatal neurodegenerative disease. Muscles
become progressively atrophic and weak because of de-
generation of motor neurons in the brain and spinal
cord. Death due to respiratory failure occurs, on average,
3.5 years after symptom onset (Haverkamp et al. 1995;
Shaw et al. 2001). The incidence of ALS is 1–2 per
100,000, but, because survival is relatively short, the
prevalence is only ∼4–7 per 100,000 (Kondo 1995). In
familial ALS (FALS), the vast majority of affected in-
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dividuals have an autosomal dominant pattern of in-
heritance. FALS accounts for 5%–10% of cases, and
they are clinically and pathologically indistinguishable
from sporadic disease (Rouleau et al. 1996; Shaw et al.
1997).
Linkage to chromosome 21q22.11 was demonstrated
in a subset of kindreds with FALS (Siddique et al. 1991),
and mutations in SOD1 (ALS1 [MIM 105400]) were
subsequently found in 20% of FALS and 3% of sporadic
ALS cases (Rosen et al. 1993; Shaw et al. 1998). Over
100 SOD1 mutations have now been reported, and the
vast majority are missense, which result in the substi-
tution of a single amino acid (Shaw et al. 2001). Mice
transgenic for mutant SOD1 develop motor neuron de-
generation by a toxic gain of function, but whether this
is due to altered metal ion handling, catalytic function,
or protein misfolding and aggregation is still debated
(Cleveland et al. 2001).
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Table 1
Two-Point LOD Score Analysis
FAMILY AND
MARKER
MARKER
POSITION
LOD SCORE at vp
.0 .1 .2 .3 .4
1:
D16S423 10.36  1.31 .55 .2 .05
D16S404 18.07 1.06 .78 .49 .24 .06
D16S3075 23.28  .87 .91 .71 .39
D16S3103 32.07 1.75 1.44 1.10 .73 .36
D16S3046 40.65 2.48 2.15 1.73 1.22 .65
D16S403 43.89 1.12 .98 .76 .50 .23
D16S3068 48.53 1.49 1.19 .89 .58 .28
D16S769 50.6 1.21 1.06 .83 .55 .26
D16S753 57.79 2.08 1.81 1.43 .98 .49
D16S409 58.46 .18 .1 .04 .01 .01
D16S517 58.46 .41 .3 .19 .10 .03
D16S3044 58.46 3.34 2.77 2.15 1.48 .76
D16S3136 62.11 2.27 1.95 1.55 1.09 .57
D16S3396 63.78 1.15 .89 .63 .38 .17
D16S419 67.4 1.42 1.14 .85 .55 .26
D16S415 67.62 3.50 2.9 2.25 1.54 .79
D16S3137 69.05 3.62 3.01 2.34 1.61 .83
D16S3032 73.2 .26 .22 .17 .10 .04
D16S3053 73.91 .99 1.01 .88 .61 .29
D16S3112 73.92 2.32 .11 .20 .16 .08
D16S503 83.55 1.75 .35 .36 .25 .11
2:
D16S423 10.36 .09 .05 .02 .00 .00
D16S403 43.89 1.81 1.44 1.03 .60 .20
D16S3068 48.53 1.18 .92 .65 .36 .11
D16S769 50.6 .92 .68 .44 .22 .06
D16S753 57.79 .77 .55 .32 .13 .02
D16S409 58.46 1.12 .85 .56 .29 .08
D16S517 58.46 .62 .43 .25 .12 .03
D16S3044 58.46 2.12 .06 .07 .06 .03
D16S3136 62.11 1.14 .44 .41 .25 .08
D16S3396 63.78 1.79 .10 .13 .07 .02
D16S419 67.4 1.65 1.29 .90 .51 .16
D16S415 67.62 1.84 1.45 1.03 .59 .20
D16S3137 69.05 1.80 1.37 .93 .50 .15
D16S3032 73.2 .14 .09 .05 .02 .00
D16S3053 73.91 1.16 .88 .57 .29 .07
D16S3112 73.92 2.07 .31 .09 .02 .00
D16S503 83.55 .27 .16 .08 .03 .01
NOTE.—Markers within the disease haplotype are in italics.
A recessive form of juvenile-onset primary lateral scle-
rosis (ALS2 [MIM 205100]) was linked to chromosome
2q33 (Hentati et al. 1994), and truncating mutations
have been detected in ALS2/alsin (Hadano et al. 2001;
Yang et al. 2001). No genes have yet been identified at
the other FALS loci: 18q 21 in one family with dominant
classical ALS (ALS3 [MIM 606640] (Hand et al. 2002),
9q34 in one family with a dominant nonfatal juvenile-
onset ALS-like disorder (ALS4 [MIM 602433]) (Chance
et al. 1998), 15q15-21 in kindreds with recessive juvenile
onset (Hentati et al. 1998), and 9q21 in five families
with ALS with frontotemporal dementia (ALS-FTD
[MIM 105550]) (Hosler et al. 2000). Mutations in tau
have been detected in families with frontotemporal de-
mentia (FTD) and Parkinsonism (FTDP) linked to 17q21
(MIM 157140) (Hutton et al. 1998), but only rarely are
family members affected by an ALS-like syndrome. The
vast majority (80%) of kindreds with dominant FALS
are unlinked.
We identified two large unrelated European kindreds
with ALS that were suitable for linkage. A consultant
neurologist examined all individuals (F1: C.E.S. and
P.N.L.; F2: V.D.J. and E.P.M.). ALS was confirmed, on
detailed pathological assessment at post mortem ex-
amination, in two affected individuals from F1 and three
from F2. Family F1 had 15 affected individuals, auto-
somal dominant inheritance, and a disease penetrance
of 83% by age 70 years. All individuals had a limb onset
of disease, mean age at onset was 38 years (range 29–51
years), and mean survival was 13 mo (range 7–27 mo).
Family F2 had eight affected individuals but several ob-
ligate gene carriers, and disease penetrance was low
(39%) by age 70 years. The F2 kindred was bigenera-
tional, without consanguinity, and fitted best with an
autosomal dominant pattern of inheritance. Four indi-
viduals had a bulbar onset of disease, and two developed
hallucinations and cognitive impairment during their ill-
ness, suggestive of FTD. The mean age at onset was 61
years (range 40–72 years), and mean survival was 35.5
mo (range 12–90 mo).
Ethical committees in both clinical centers approved
genetic research on ALS. Following receipt of informed
consent, blood was drawn and DNA extracted from 48
members of F1 (5 affected) and 146 members of F2 (5
affected). By genotyping the spouses and offspring, we
were able to recreate the genotypes and haplotypes of
deceased affected individuals (5 in F1 and 1 in F2) (see
fig. 1). No mutations in SOD1 were detected by se-
quencing two affected members from each family (as
described in Shaw et al. [1998]). Tau mutations were
excluded by direct sequencing in two members of F2 (as
described in Rizzu et al. [1999]). In both families, linkage
to reported ALS loci was confidently excluded for 18q21
(maximal two-point LOD scores of 0.33 for D18S846
[F1] and of 0.31 at D18S35 [F2]) and 9q21 (LOD scores
of 0.32 at D9S1122 [F1] and of 0.8 at D9S922 [F2]).
Power calculations were made, by use of SLINK, for
a single marker with six alleles (Ott 1989; UK Human
Genome Mapping Project Resource Centre). The max-
imum achievable LOD score, for 19 members of F1, was
3.06 and, for 35 members of F2, was 2.04 (by use of
100 replications and identical assumptions as for FAST-
LINK; see below). A fluorescent dye-labeled medium-
density microsatellite marker set (∼10-cM map, PRISM)
was used for genotyping, and the PCR products were
run out on ABI 377 and 3100 sequencers and analyzed
by use of GENOTYPER software (ABI Biosystems). A
consistent genotype was obtained in 95% of alleles,
and inheritance was checked, by use of PEDCHECK
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Figure 2 Graphical representation of the three-point LOD scores for F1 and F2
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(O’Connell and Weeks 1998; UK Human Genome Map-
ping Project Resource Centre), prior to linkage. FAST-
LINK (Cottingham et al. 1993; UK Human Genome
Mapping Project Resource Centre) was used with the
following assumptions: autosomal dominant inheritance
with age-dependent penetrance, no phenocopies, a dis-
ease gene frequency of 0.00001, and equal marker allele
frequencies. The age cutoff for liability classes was based
on reports published elsewhere (Hand et al. 2002) and
modified with penetrance calculated in each family: (1)
age !46 years, , ; (2) age 146F1p 50% F2p 20%
years, , ; and (3) spouses wereF1p 85% F2p 40%
given the background population risk.
Given the very large number of individuals in both
pedigrees, we chose an “affecteds-only” analysis. Ge-
notyping of 385 markers was initially performed on 5
affected individuals from F1 (with an additional 12 un-
affected spouses and offspring to recreate 5 further af-
fected individuals) and 5 affected individuals from F2
(with an additional 3 unaffected offspring and 1 spouse
and to recreate another affected individual). When al-
leles were not shared between affected individuals, mark-
ers were excluded from further analysis. When alleles
were shared in three or more affected individuals in ei-
ther family, markers were regenotyped (with additional
neighboring markers) in the extended kindred (as for
SLINK; see above) and tested for linkage by use of FAST-
LINK (data submitted for review but not shown). In
F1, only two regions generated LOD scores 11.0: chro-
mosome 16 (D16S415, , and D16S3136,LODp 3.5
) and chromosome 9 (D9S1677LODp 2.27 LODp
). The maximum three-point LOD score across1.68
chromosome 9 was only 0.251, and SIMWALK 2.82
(Weeks et al. 1995) produced no shared haplotype in
the affected individuals. In F2, there were three regions
with LOD scores ∼1.0: chromosome 16 (D16S415,
), chromosome 6 (D6S460, ),LODp 1.84 LODp 1.01
and chromosome 11 (D11S904, ), but theLODp 0.97
maximum three-point LOD scores were 0.18 and 0.23
for chromosomes 6 and 11, respectively; again, haplo-
type analysis excluded these regions.
The region on chromosome 16 was fine mapped with
24 additional markers in both families. Table 1 details
the two-point LOD scores and shows six markers to be
above 2 in F1, with a maximal two-point LOD score of
3.62 ( ) at D16S3137. Sine the pedigrees were toovp 0
large for GENEHUNTER, FASTLINK was used to cal-
culate three-point LOD scores, and a maximum of 3.85
was reached for markers D16S415 and D16S3137 (fig.
2). Haplotype analysis in F1 demonstrated recombinant
events, with flanking markers D16S3075 and D16S3112
narrowing the region to ∼30 cM (fig. 1; table 1). In F2,
the scores were more modest, but seven markers had
LOD scores 11.0, with a maximum of 1.84 at D16S415
and 1.80 at D16S3137 ( ) (table 1). The maximumvp 0
three-point LOD score for F2 was 2.10 for markers
D16S419 and D16S415 (fig. 2). Empirical P values for
the maximum two-point LOD scores at chromosome 16,
for F1, are and, for F2, are , by use ofP ! .0001 P ! .01
SLINK (Ott 1989). Although positive LOD scores were
recorded between D16S403 and D16S517 in F2, a con-
sistent haplotype could not be created from these ge-
notypes, thus excluding linkage to this region. A shared
haplotype was observed in the affected individuals of
F2, and recombinant events in the affected individual
III:7 narrowed the conserved haplotype to a 10.1-cM
region (flanking markers: D16S3396 and D16S3112)
(fig. 1). This haplotype was also seen in one unaffected
sibling and one offspring of III:7 (reviewed but not de-
picted, to maintain confidentiality).
The overlapping region shared between the two fami-
lies corresponds to 10.14 cM on the Marshfield map
and ∼4.5 Mb of sequenced genome. A systematic search
of publicly available databases (Ensembl, Genome Da-
tabase, NCBI, and UCSC) has identified 18 known and
70 putative genes in this region. Candidate genes,
screened but, to date, without a mutation identified that
segregates with disease, include: CAGF9, containing a
polyglutamine tract of nine repeats; FTS, an ubiquitin-
conjugating enzyme; CAPNS2, a cysteine protease sub-
unit; and SALL1, a transcriptional regulator of higher
chromatin order. We have begun screening the remaining
genes for mutations, prioritized on the basis of their
expression in the nervous system and potential role in
the pathogenesis of ALS.
ALS is a rapidly fatal late-onset neurodegenerative dis-
order for which families suitable for linkage are very
rare. Here, we report two unrelated kindreds that are
linked to an overlapping region on chromosome 16q12-
13. We are aware of two other unrelated families with
ALS linked to regions of chromosome 16 that overlap
this locus (R. H. Brown and J. de Belleroche, personal
communication). This suggests that mutation of a gene
in this region is a significant cause of FALS. The iden-
tification of another FALS gene will enable more families
to undergo predictive and prenatal testing. It will also
allow the development of transgenic and cellular models
of ALS that will advance our understanding of disease
mechanisms and help develop more effective therapies.
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